EditForce Inc.

5:00 PM - 5:15 PM (JST), Tuesday, March 5, 2019 ・ 2nd Floor
EditForce Inc. is a technology start-up company established in 2015 in Fukuoka, Japan. We are specialized in designing and producing sequence-specific binding proteins to RNA or DNA based on PPR (Pentatricopeptide repeat) motif. Our technology is novel and will be a powerful alternative to existing technologies for gene editing (CRISPR/Cas9, TALEN, ZFN) and RNA silencing (siRNA, anti-sense, etc.). We aspire to partner with pharma and biotech who are keen to develop new therapies for human diseases through PPR technology.
Company Type:
Privately Funded Company
Company HQ State:
Not Provided
Company HQ Country:
Year Founded:
Main Therapeutic Focus:
Gene/Cell Therapy
Lead Product in Development:
Patent on DNA/RNA editing technology using PPR protein engineering technology
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
EditForce Inc.